User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Probiotic and prebiotic claims in Europe : seeking a clear roadmap.

  1. Hickson M., D'Souza A. L, Muthu N., Rogers T. R, Want S., Rajkumar C., Bulpitt C. J, Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial, 10.1136/bmj.39231.599815.55
  2. , Scientific Opinion on the substantiation of a health claim related to fermented milk containing Lactobacillus casei DN-114 001 plus yoghurt symbiosis (Actimel®), and reduction of Clostridium difficile toxins in the gut of patients receiving antibiotics an : Lactobacillus casei DN-114 001 plus yoghurt symbiosis and reduction of the presence of Clostridium difficile toxins in the gut, 10.2903/j.efsa.2010.1903
  3. Kyne L., Hamel M. B., Polavaram R., Kelly C. P., Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile, 10.1086/338260
  4. Wilcox M.H., Cunniffe J.G., Trundle C., Redpath C., Financial burden of hospital-acquired Clostridium difficile infection, 10.1016/s0195-6701(96)90122-x
  5. , Scientific Opinion on the substantiation of health claims related to lactulose and decreasing potentially pathogenic gastro-intestinal microorganisms (ID 806) and reduction in intestinal transit time (ID 807) pursuant to Article 13(1) of Regulation (EC) N : Lactulose related health claims, 10.2903/j.efsa.2010.1806
  6. EFSA J, 8, 1763 (2010)
Bibliographic reference Guarner, Francisco ; Sanders, Mary Ellen ; Gibson, Glenn ; Klaenhammer, Todd ; Cabana, Michael ; et. al. Probiotic and prebiotic claims in Europe : seeking a clear roadmap.. In: The British Journal of Nutrition : an international journal of nutritional science, Vol. 106, no. 11, p. 1765-1767 (2011)
Permanent URL http://hdl.handle.net/2078.1/105102